DermaSensor, Inc.
PrivateLast Round
Series B
Extension
Sep 9, 2026
Total Funding Raised
$47.31M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
DermaSensor, Inc. is a medical device company that has developed an FDA-cleared, AI-powered handheld device that uses optical spectroscopy to non-invasively assess suspicious skin lesions for melanoma, basal cell carcinoma, and squamous cell carcinoma.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DermaSensor, Inc. Comparables
Compare DermaSensor, Inc. with similar companies based on industry and business-model similarity.
DermaSensor, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 9, 2026 | ||||
| Series B | Oct 2, 2025 | ||||
| Series A Extension | Jun 15, 2022 | ||||
| Series A | Jun 4, 2020 | ||||
| Series A Extension | Dec 18, 2018 |
Key People
Founding team and executive leadership
DermaSensor, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SternAegis Ventures | Series A |
| Ceros Capital Markets | Series A |
| Pier 70 Ventures | Series B |
| Kern Venture Group | Series B |
| Ceros Capital Markets | Series A Extension |
| Wealthing VC Club | Series A Extension |
| Miami Angels | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2026
$4M round completed.
- Aug 22, 2026
Monthly visitors grew 59% MoM, reaching 29.6K.
Recent news
Latest coverage and updates
- partners_withSep 18, 2026
DermaSensor, Inc. partners with Medical Place.
- receives_financingSep 9, 2026
DermaSensor, Inc. received financing of $1M in community investment round on Sep 9th '26.
- receives_financingSep 9, 2026
DermaSensor, Inc. received financing of $4M in Series B on Oct 1st '25.
- hiresJun 30, 2026
DermaSensor, Inc. hired Carolyn Walsh as Chief Commercial Officer on May 15th '25.
- recognized_asJun 26, 2026
DermaSensor, Inc. recognized as Top 100 Healthcare Technology Companies of 2024 on Jun 26th '26.
DermaSensor, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DermaSensor, Inc.'s valuation, stock price, and market status.
Is DermaSensor, Inc. a public or private company?
DermaSensor, Inc. is a private company.
What is the current stock price of DermaSensor, Inc.?
DermaSensor, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is DermaSensor, Inc. worth (valuation)?
Valuation information for DermaSensor, Inc. is not publicly available.
Can I buy DermaSensor, Inc. stock?
DermaSensor, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was DermaSensor, Inc.'s last funding round?
DermaSensor, Inc.'s most recent funding round was Series B on October 2, 2025.
Who are the main investors in DermaSensor, Inc.?
Key investors in DermaSensor, Inc. include SternAegis Ventures, Ceros Capital Markets.
Will DermaSensor, Inc. IPO soon?
No public IPO plans have been announced for DermaSensor, Inc..
How can I track DermaSensor, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DermaSensor, Inc.'s secondary market activity and sign up for updates.